Ultralife Corp.

How big is Ultralife Corp.?

As of Jun 18, Ultralife Corp. has a market capitalization of 174.84 million, with net sales of 173.27 million and a net profit of 5.38 million over the latest four quarters. Shareholder's funds are reported at 134.00 million, and total assets amount to 220.45 million.

As of Jun 18, Ultralife Corp. has a market capitalization of 174.84 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 173.27 million, while the sum of net profit for the same period is 5.38 million.<BR><BR>As of Dec 24, the shareholder's funds are reported at 134.00 million, and total assets amount to 220.45 million.

What does Ultralife Corp. do?

Ultralife Corp. is a micro-cap company in the Electronics & Appliances industry, specializing in power solutions and communications systems, with recent net sales of $51 million and a market cap of $174.84 million.

Overview:<BR>Ultralife Corp. operates in the Electronics & Appliances industry, providing power solutions and communications systems, and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 51 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 2 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 174.84 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 30.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.34 <BR>Return on Equity: 3.95% <BR>Price to Book: 1.28 <BR><BR>Contact Details:<BR>Address: 2000 Technology Pkwy, NEWARK NY : 14513-2175 <BR>Tel: 1 315 3327100 <BR>Website: http://ultralifecorporation.com

Should I buy, sell or hold Ultralife Corp.?

Who are in the management team of Ultralife Corp.?

As of March 2022, Ultralife Corp.'s management team includes Independent Chairman Mr. Bradford Whitmore, President and CEO Mr. Michael Popielec, and Independent Directors Mr. Thomas Saeli, Mr. Robert Shaw, and Mr. Ranjit Singh. The team features a combination of executive leadership and independent directors.

As of March 2022, the management team of Ultralife Corp. includes the following individuals:<BR><BR>- Mr. Bradford Whitmore, who serves as the Independent Chairman of the Board.<BR>- Mr. Michael Popielec, who is the President, Chief Executive Officer, and a Director.<BR>- Mr. Thomas Saeli, who is an Independent Director.<BR>- Mr. Robert Shaw, who is also an Independent Director.<BR>- Mr. Ranjit Singh, who serves as an Independent Director.<BR><BR>In summary, the management team consists of a mix of executive leadership and independent directors.

Is Ultralife Corp. technically bullish or bearish?

As of September 8, 2025, Ultralife Corp. exhibits a mildly bearish technical trend, with underperformance of -23.88% over the year compared to the S&P 500's 17.14%, despite a short-term gain of 2.73% against the S&P's 1.05%.

As of 8 September 2025, the technical trend for Ultralife Corp. has changed from sideways to mildly bearish. The weekly MACD and KST indicators are both mildly bearish, while the monthly MACD and KST are bearish. The Bollinger Bands also indicate a mildly bearish stance on both weekly and monthly time frames. Moving averages show a mildly bullish signal on the daily chart, but this is overshadowed by the overall bearish indicators. The Dow Theory shows no trend in both weekly and monthly assessments. <BR><BR>In terms of performance, Ultralife Corp. has underperformed against the S&P 500 over the year, with a return of -23.88% compared to the S&P 500's 17.14%. However, it has shown some strength in the short term, with a 1-week return of 2.73% versus the S&P 500's 1.05%. Overall, the current technical stance is mildly bearish.

Is Ultralife Corp. overvalued or undervalued?

As of October 24, 2025, Ultralife Corp. is considered attractive due to its undervalued status, with a P/E ratio of 30 compared to the industry average of 45.18, a competitive EV to EBITDA ratio of 15.03, and a price to book value of 1.19, despite underperforming the S&P 500 over the past year while achieving a 20.87% return over three years.

As of 24 October 2025, the valuation grade for Ultralife Corp. has moved from very expensive to attractive, indicating a significant improvement in its perceived value. The company appears to be undervalued, especially when considering its P/E ratio of 30, which is notably lower than the peer average of approximately 45.18 for similar companies, and an EV to EBITDA ratio of 15.03, which is competitive within the industry. Additionally, the price to book value stands at 1.19, suggesting that the stock is trading at a reasonable premium to its book value.<BR><BR>In comparison to its peers, Ultralife Corp. has a lower valuation profile than Allient, Inc., which has a P/E ratio of 128.16, and Solid Power, Inc., which is currently in a risky category with a negative P/E ratio. This positions Ultralife favorably within its sector. Notably, while the stock has underperformed against the S&P 500 over the past year and year-to-date, it has shown resilience with a 20.87% return over three years, contrasting sharply with the S&P 500's 78.85% return during the same period.